138 related articles for article (PubMed ID: 14551314)
1. Chemoradiotherapy in unresectable squamous cell head and neck cancer.
Blot E; Staub E
J Clin Oncol; 2003 Oct; 21(20):3887; author reply 3887-8. PubMed ID: 14551314
[No Abstract] [Full Text] [Related]
2. Chemotherapy of squamous cell carcinoma of the head and neck.
Greenberg BR
Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
[No Abstract] [Full Text] [Related]
3. Second-line chemotherapy in head and neck cancer: what should we expect?
Büntzel J; Micke O
Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
[No Abstract] [Full Text] [Related]
4. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Awada A; Ismael G
Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
[TBL] [Abstract][Full Text] [Related]
5. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
Forastiere AA
J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
[No Abstract] [Full Text] [Related]
6. Palliation in incurable head and neck cancers: chemotherapy?
Pantvaidya GH; D'Cruz AK; Prabhash K
J Clin Oncol; 2005 Nov; 23(31):8128-9; author reply 8129-30. PubMed ID: 16258117
[No Abstract] [Full Text] [Related]
7. [Role of systemic chemotherapy in the treatment of squamous cell carcinoma of the head and neck].
Bruntsch U
Sonderb Strahlenther Onkol; 1987; 81():92-8. PubMed ID: 3547731
[No Abstract] [Full Text] [Related]
8. Induction chemotherapy in the management of squamous cell cancer of the head and neck.
Posner MR; Colevas AD
Cancer J Sci Am; 1997; 3(2):73-5. PubMed ID: 9099455
[No Abstract] [Full Text] [Related]
9. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
Murdoch D
Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
[TBL] [Abstract][Full Text] [Related]
14. Palliative treatment of head and neck squamous cancer with cisplatin and hydroxyurea.
Taylor SG; Showel J
Cancer Treat Rep; 1984 Jun; 68(6):932-3. PubMed ID: 6203641
[No Abstract] [Full Text] [Related]
15. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
16. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
17. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic and adverse effects of topotecan combined with cisplatin for treatment of advanced squamous cell lung cancer and head and neck cancer].
Xiang Y; Li QY; Shao JH; Yang JZ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):491-3. PubMed ID: 18359722
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of systemic therapy in head and neck cancer.
Cohen EE; Lingen MW; Vokes EE
J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
